Picture of Biotika as logo

1BSL01AE Biotika as Income Statement

0.000.00%
sk flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Annual income statement for Biotika as, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2016
December 31st
2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue24.3242619.917.6
Cost of Revenue
Gross Profit14.112.112.811.19.91
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses2320.124.41815.5
Operating Profit1.273.921.631.942.16
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes1.163.711.472.52.73
Provision for Income Taxes
Net Income After Taxes0.9152.891.132.022.28
Net Income Before Extraordinary Items
Net Income0.9152.891.132.022.28
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income0.9152.891.132.022.28
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.30.0711.722.813.23
Dividends per Share

Or unlock with your email

Or unlock with your email